Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2015-002096-14-SE
EUCTR2015-002096-14-SE
Active, not recruiting
Not Applicable

Examine whether treatment with methylphenidate facilitates work rehabilitation for persons with long-term pain and mental fatigue after traumatic brain injury. - Methylphenidate: work rehabilitation of people with pain and mental fatigue after brain injury

Sahlgrenska University Hospital0 sitesJuly 3, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsong-term pain and mental fatigue after traumatic brain injury and work rehabilitation.Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
DrugsRitalin (methylphenidate)

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ong-term pain and mental fatigue after traumatic brain injury and work rehabilitation.
Sponsor
Sahlgrenska University Hospital
Status
Active, not recruiting
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 3, 2015
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Sahlgrenska University Hospital

Eligibility Criteria

Inclusion Criteria

  • •1\. Subjects who suffer from mental fatigue and pain due to a head trauma \>12 months earlier. The persons are attended to by the Department of Neurology, SU/S. 2\. Age 20 – 65\. 3\. Glasgow Outcome Scale (extended), moderate disability (\~5\) or better recovery.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 60
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •1\. Significant co\-morbidity. Persons, where pain is the main problem. Persons with pain of other genesis as well as pain prone persons or a high degree of somatisation. 2\. Major depression (according to DSM IV) prior to the trauma. 3\. Organic personality disorder or other organic CNS disorder. Women of child\-bearing age who are not on contraceptives. Pregnant women, Alcohol or drug abuse.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Investigating the effectiveness of methylphenidate and combination of magnesium and zinc and calcium in treatment of patients with attention deficit hyperactivity disorder (ADHD) in Zahedan City
IRCT2015092624209N1Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser40
Completed
Phase 3
Investigating the effectiveness of methylphenidate and multi chain polyunsaturated fatty acids in treatment of patients with attention deficit hyperactivity disorder (ADHD) in Zahedan CityAttention deficit hyperactivity disorder (ADHD).Disturbance of activity and attention
IRCT2015092724209N2Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser40
Recruiting
Phase 1
Evaluation of the efficacy of Methylphenidate and modafinil in the treatment of excessive daily sleepiness in patients with drug-resistant epilepsy and comparison with the control groupEpilepsy.Epilepsy and recurrent seizures
IRCT20171030037093N22Esfahan University of Medical Sciences84
Recruiting
Phase 2
The effects of methylphenidate and atomoxetine on emotional intelligence, executive function and self-efficacy of 12-18-year-old adolescents with ADHD
IRCT20160523028008N31Hamedan University of Medical Sciences76
Completed
Phase 3
The effect of magnesium in patients with attention deficit hyperactivity disorder
IRCT20160813029327N19Islamic Azad University62